Welcome visitor Log In - or - Register
0 items /
View Cart
Check Out
four ways
Quick Search:
Skip Navigation LinksHome > Kinase Inhibitors > EGFR Mutants > TAK-788 (Mobocertinib)
TAK-788 (Mobocertinib)
TAK-788 (Mobocertinib, AP32788) is a potent and selective covalent inhibitor targeting EGFR and human EGFR 2 (HER2) exon 20 insertion mutations, with minimal inhibitory activity against Wt-EGFR. It has been granted Breakthrough Therapy Designation by FDA for the treatment of lung cancer with HER2 mutations or EGFR mutations including exon 20 insertion mutations.
Catalog NO: CT-TAK788
Synonym: Mobocertinib, AP32788
CAS NO: 1847461-43-1
Mol. Formula: C32H39N7O4
MW: 585.7
** 99.5% Pure. in vivo Quality Material. Clean and impeccable (Data Attached). Anhydrous, salt-free, validated by a spot-on Elemental Analysis. Bulk Stock (Get quote for 10G, 20G). Prompt..